Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/9QhIuE89Bic   CoVid patients treated with tocilizumab and corticosteroids enjoy a 54% lower in-hospital mortality.  A study of 3098 patients treated within the giant metro New York City Northwell Health System was just released on the pre-print server medrixiv.org.   The study of various immunomodulators’ effects on the deadly CoVid cytokine storm showed that Actemra+steroids reduced mortality best followed by steroids alone at 30% and Actemra alone at 28%.  Anakinra, another modulator, showed no effect.   This data adds another therapy option for clinicians treating life-threatening cases of CoVid19.  As always, the best treatment of any disease is prevention.  You control that by following MDW: masking, distancing, and washing.   https://www.medrxiv.org/content/10.1101/2020.06.16.20126714v1.full.pdf   #covid #actemra #steroids #tocilizumab #mortality